Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation

Antía Figueroa-Romero, Daniel Bissombolo, Martin Meremikwu, Arsène Ratsimbasoa, Charfudin Sacoor, Iwara Arikpo, Elsha Lemba, Abel Nhama, Rianasoambolanoro Rakotosaona, Mireia Llach, Clara Pons-Duran, Sergi Sanz, Laurence Ma, Cécile Doderer-Lang, Christina Maly, Elaine Roman, Franco Pagnoni, Alfredo Mayor, Didier Menard, Raquel González, Clara Menéndez

Open source

DOI
10.1016/s2214-109x(23)00414-x
Published
2023-11
Container
The Lancet Global Health
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-23-00414-x,
  title = {Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation},
  author = {Antía Figueroa-Romero and Daniel Bissombolo and Martin Meremikwu and Arsène Ratsimbasoa and Charfudin Sacoor and Iwara Arikpo and Elsha Lemba and Abel Nhama and Rianasoambolanoro Rakotosaona and Mireia Llach and Clara Pons-Duran and Sergi Sanz and Laurence Ma and Cécile Doderer-Lang and Christina Maly and Elaine Roman and Franco Pagnoni and Alfredo Mayor and Didier Menard and Raquel González and Clara Menéndez},
  year = {2023},
  journal = {The Lancet Global Health},
  doi = {10.1016/s2214-109x(23)00414-x},
  url = {https://doi.org/10.1016/s2214-109x(23)00414-x}
}

RIS

TY  - JOUR
TI  - Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation
AU  - Antía Figueroa-Romero
AU  - Daniel Bissombolo
AU  - Martin Meremikwu
AU  - Arsène Ratsimbasoa
AU  - Charfudin Sacoor
AU  - Iwara Arikpo
AU  - Elsha Lemba
AU  - Abel Nhama
AU  - Rianasoambolanoro Rakotosaona
AU  - Mireia Llach
AU  - Clara Pons-Duran
AU  - Sergi Sanz
AU  - Laurence Ma
AU  - Cécile Doderer-Lang
AU  - Christina Maly
AU  - Elaine Roman
AU  - Franco Pagnoni
AU  - Alfredo Mayor
AU  - Didier Menard
AU  - Raquel González
AU  - Clara Menéndez
PY  - 2023
JO  - The Lancet Global Health
DO  - 10.1016/s2214-109x(23)00414-x
UR  - https://doi.org/10.1016/s2214-109x(23)00414-x
ER  - 

APA

Figueroa-Romero, A., Bissombolo, D., Meremikwu, M., Ratsimbasoa, A., Sacoor, C., Arikpo, I., Lemba, E., Nhama, A., Rakotosaona, R., Llach, M., Pons-Duran, C., Sanz, S., Ma, L., Doderer-Lang, C., Maly, C., Roman, E., Pagnoni, F., Mayor, A., Menard, D., González, R., & Menéndez, C. (2023). Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(23)00414-x

Source records